EJSO (European Journal of Surgical Oncology) is the Official Journal of the European Society of Surg

To access the EJSO please login to the members area "My ESSO"

EJSO (European Journal of Surgical Oncology) is the Official Journal of the European Society of Surgical Oncology and BASO - the Association for Cancer Surgery.

EJSO aims to educate and inform about the many subspecialty disciplines of cancer surgery. The EJSO publishes original scientific articles, reviews, clinical trials, news and views, and other relevant material. The journal seeks to inform its worldwide print and electronic readership through excellence, clarity, simplicity and concise presentation of the written word and diagram.

Membership of ESSO includes the subscription to EJSO. 

Membership of ESSO now also includes the EJSO App

Key benefits include:

  • Browse latest issues or jump to featured articles with just a tap!
  • Start reading while downloading: no more waiting!
  • Watch videos and interact with content
  • Save articles for offline reading and add favorites to reading lists
  • Share articles via social media or email an article to a colleague

Download now from ITunes and Google play.

The 2020 Impact Factors were released by Clarivate Analytics in June 2021. The new Impact Factor for the EJSO is 4.424 (up from 3.959 in 2019).

2020 Impact Factor: 4.424

Previous impact factors

Submitting papers for publication

The Editors welcome submissions from prospective authors in respect of Editorials on any subject of relevance to cancer surgical practice; Original Articles; specialist and general Review Articles; Educational Articles; Technical or "How I do it" Articles; News Items; Conference Reports; and Letters on matters of general interest or on specialist topics.

Research areas include: epidemiology and preventative aspects of oncology; diagnosis, including imaging; all aspects of therapy, including radiotherapy and chemotherapy; applications of new equipment to surgical and clinical oncology; methods of assessing results of treatment; computing in relation to oncology. The Editors are also pleased to accept clinical curios, personal commentaries and other original material of up to three hundred words. Concise, well-written, contextual and informative obituaries on individuals who have made a significant contribution to the science or practice of cancer surgery will also be considered for publication.

Read more about paper submission and instructions to authors on the publisher's website.

ESSO Industry Partners